Skip to main content
. 2022 Jul 8;13:940009. doi: 10.3389/fimmu.2022.940009

Figure 2.

Figure 2

Kaplan-Meier analyses of progression-free survival (A) and overall survival (B) in the two groups before PSM. DEB-TACE+ICIs, drug-eluting beads transarterial chemoembolization combined with immune checkpoint inhibitors; PSM, propensity score matching.